The use of antigen presenting cell/tumour cell hybrids for the in vitro induction of tumour-specific T cells
Malignant tumours are the second main cause of mortality worldwide, with haematological malignancies representing 10%. Current treatment strategies, such as chemotherapy, radiotherapy, and stem cell transplantation, are mostly effective but may induce serious side effects. In addition, tumours are d...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Leicester
2011
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.551697 |